Description and optimization of a multiplex bead-based flow cytometry method (MBFCM) to characterize extracellular vesicles in serum samples from patients with hematological malignancies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Cancer Gene Therapy, S.
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2022
- Event
-
Veröffentlichung
- (who)
-
Springer Science and Business Media LLC
- (when)
-
2022
- Creator
-
Li, Lin
Görgens, André
Mussack, Veronika
Pepeldjiyska, Elena
Hartz, Anne Sophie
Rank, Andreas
Schmohl, Jörg
Krämer, Doris
Andaloussi, Samir El
Pfaffl, Michael W.
Schmetzer, Helga
- DOI
-
10.1038/s41417-022-00466-1
- URN
-
urn:nbn:de:bvb:384-opus4-953753
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Li, Lin
- Görgens, André
- Mussack, Veronika
- Pepeldjiyska, Elena
- Hartz, Anne Sophie
- Rank, Andreas
- Schmohl, Jörg
- Krämer, Doris
- Andaloussi, Samir El
- Pfaffl, Michael W.
- Schmetzer, Helga
- Universität Augsburg
- Springer Science and Business Media LLC
Time of origin
- 2022
Other Objects (12)
Description and optimization of a multiplex bead-based flow cytometry method (MBFCM) to characterize extracellular vesicles in serum or culture supernatants samples from patients with hematological malignancies
Deubiquitinases in hematological malignancies
Flow Cytometry in Pediatric Malignancies
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Targeting immune checkpoints in hematological malignancies
Cellular immunotherapy for refractory hematological malignancies
IL-31, itch and hematological malignancies
Role of CD47 in Hematological Malignancies
Targeting splicing for hematological malignancies therapy
Description and optimization of a multiplex bead-based flow cytometry method (MBFCM) to characterize extracellular vesicles in serum or culture supernatants samples from patients with hematological malignancies
Deubiquitinases in hematological malignancies
Flow Cytometry in Pediatric Malignancies
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Targeting immune checkpoints in hematological malignancies
Cellular immunotherapy for refractory hematological malignancies
IL-31, itch and hematological malignancies
Role of CD47 in Hematological Malignancies
Targeting splicing for hematological malignancies therapy
Description and optimization of a multiplex bead-based flow cytometry method (MBFCM) to characterize extracellular vesicles in serum or culture supernatants samples from patients with hematological malignancies
Deubiquitinases in hematological malignancies
Flow Cytometry in Pediatric Malignancies
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Targeting immune checkpoints in hematological malignancies
Cellular immunotherapy for refractory hematological malignancies
IL-31, itch and hematological malignancies
Role of CD47 in Hematological Malignancies